Brief: Shenzhen Hepalink Says OncoQuest Inc Plans To Sell Assets To South Korea's Dual Industrial
21/04/2020 02:07
April 21 (Reuters) - Shenzhen Hepalink Pharmaceutical Group
Co Ltd 002399.SZ :
* SAYS ITS U.S. UNIT'S JOINT STOCK COMPANY ONCOQUEST INC
PLANS TO
SELL DRUG-RELATED ASSETS TO SOUTH KOREA'S DUAL INDUSTRIAL CO LTD
Source text in Chinese: https://bit.ly/3cw9gFR
Further company coverage: 002399.SZ 078590.KQ
(Reporting by Hong Kong newsroom)
((twinnie.siu@thomsonreuters.com; 852-2841 5763;))
Recent news on Shenzhen Hepalink Pharmaceutical Co
See all newsBrief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina
Brief: Shenzhen Hepalink Pharmaceutical Says H1710 Injection Received Approval For From NMPA